Scientists spy on lung bugs to unlock COPD secrets
NCT ID NCT04849104
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tracks 210 people with COPD over 4 years to see how bacteria and other microbes in the airways relate to lung function decline. Researchers collect fluid from the lungs during a bronchoscopy and analyze the microbial DNA. The goal is to understand why COPD gets worse in some people, not to test a new drug.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help identify which airway bacteria or fungi are linked to COPD worsening, pointing toward future diagnostic or treatment targets.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly improve patient health, and results may not lead to new therapies for years.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiaotong University
Shanghai, Shanghai Municipality, 200011, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smart breathing machines at home: a new way to predict COPD crises?
- Breathing easy? new X-Ray method may spot COPD decline early
- Could a common heart drug cut COPD hospitalizations?
- Which inhaler breathes better? a Head-to-Head COPD showdown
- Could tiny lung valves revive heart and muscle strength in COPD?
- One lung or two? surgery trial aims to find the best approach for severe COPD